On November 1, 2017, Chuck and Gena Norris filed a lawsuit against 11 companies involved in the manufacture and distribution of two gadolinium-based contrast agents (GBCAs).  The $10 million lawsuit was filed in San Francisco County Superior Court by Todd Walburg of Cutter Law.  While it is not the only lawsuit that has been filed recently against MRI contrast agent manufacturers, it is the first high-profile case.

Chuck and Gena Norris have brought much needed media attention to the issue of gadolinium retention from contrast-enhanced MRIs.  We hope the media will continue to investigate the problems involving gadolinium-based contrast agents.  We believe that Gena’s case is just the tip of the iceberg when it comes to gadolinium toxicity from GBCAs.

We anticipate that there will be ongoing media coverage of this story and that readers will get the most up-to-date information by doing a search of the Internet.